scholarly article | Q13442814 |
P2093 | author name string | Andrew R Tapper | |
Paul D Gardner | |||
Rubing Zhao-Shea | |||
Xueyan Pang | |||
Linzy M Hendrickson | |||
P2860 | cites work | Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas | Q43925474 |
Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice | Q44292703 | ||
Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors | Q44410731 | ||
Intracranial self-administration of ethanol within the ventral tegmental area of male Wistar rats: evidence for involvement of dopamine neurons. | Q44755323 | ||
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. | Q44904935 | ||
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition | Q45399038 | ||
The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system | Q46173380 | ||
Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area. | Q46419882 | ||
Is an alpha-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol? | Q46498223 | ||
Nicotinic acetylcholine receptors in the anterior, but not posterior, ventral tegmental area mediate ethanol-induced elevation of accumbal dopamine levels | Q46680367 | ||
Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors. | Q46843651 | ||
Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine | Q48346302 | ||
Characterization of ethanol-induced dopamine elevation in the rat nucleus accumbens | Q48350604 | ||
The effects of ethanol on dopaminergic neurons of the ventral tegmental area studied with intracellular recording in brain slices | Q48504203 | ||
Two brain sites for cannabinoid reward. | Q48556363 | ||
Nicotine activates and desensitizes midbrain dopamine neurons | Q48590165 | ||
Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine | Q48593995 | ||
Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues. | Q51977924 | ||
Regional heterogeneity for the intracranial self-administration of ethanol within the ventral tegmental area of female Wistar rats. | Q52168177 | ||
Involvement of nicotinic receptors in alcohol self-administration. | Q52170503 | ||
Ethanol directly excites dopaminergic ventral tegmental area reward neurons. | Q52172659 | ||
Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. | Q52290825 | ||
Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment | Q71865726 | ||
The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine | Q72723449 | ||
Role of the subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol | Q79786575 | ||
Mammalian nicotinic acetylcholine receptors: from structure to function | Q24647069 | ||
Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. | Q24681363 | ||
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors | Q28245329 | ||
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation | Q28250054 | ||
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid | Q28278033 | ||
Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse | Q28508736 | ||
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization | Q28588299 | ||
Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice | Q30475871 | ||
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking | Q30502320 | ||
Sensitization of ventral tegmental area dopamine neurons to the stimulating effects of ethanol | Q33819505 | ||
Varenicline reduces alcohol self-administration in heavy-drinking smokers | Q33825408 | ||
Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes | Q33861982 | ||
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence | Q33870433 | ||
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial | Q33997418 | ||
Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area | Q34398910 | ||
Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, cross-tolerance, and genetic factors. | Q34610366 | ||
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum | Q36933882 | ||
Site-specific microinjection of baclofen into the anterior ventral tegmental area reduces binge-like ethanol intake in male C57BL/6J mice | Q37318993 | ||
Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area | Q37387731 | ||
Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice | Q37467418 | ||
Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system | Q37478295 | ||
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. | Q38405712 | ||
Alcohol modulation of neuronal nicotinic acetylcholine receptors is alpha subunit dependent | Q40724473 | ||
The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats | Q43228295 | ||
P433 | issue | 30 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | alcohol consumption | Q2647488 |
varenicline | Q411330 | ||
P304 | page(s) | 10169-10176 | |
P577 | publication date | 2010-07-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption | |
P478 | volume | 30 |
Q36821304 | A preliminary investigation of varenicline for heavy drinking smokers |
Q34385515 | Activation of GABAergic neurons in the interpeduncular nucleus triggers physical nicotine withdrawal symptoms |
Q46245760 | Acute Ethanol Administration Upregulates Synaptic α4-Subunit of Neuronal Nicotinic Acetylcholine Receptors within the Nucleus Accumbens and Amygdala. |
Q37698964 | Association of the CHRNA4 neuronal nicotinic receptor subunit gene with frequency of binge drinking in young adults |
Q37259110 | Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selective α4β2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in rats |
Q38594528 | Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs |
Q36372867 | Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse |
Q36877440 | Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers |
Q52639267 | Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs. |
Q37103329 | Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. |
Q34940888 | Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization |
Q36319552 | Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse |
Q36746564 | Exposure to nicotine increases nicotinic acetylcholine receptor density in the reward pathway and binge ethanol consumption in C57BL/6J adolescent female mice |
Q37635751 | Genes and Alcohol Consumption: Studies with Mutant Mice |
Q47311042 | Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats. |
Q30441131 | How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use? |
Q35518471 | Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal |
Q30448803 | Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations |
Q33859960 | Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse |
Q39237094 | Modulation of ethanol reward sensitivity by nicotinic acetylcholine receptors containing the α6 subunit |
Q34809762 | Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence |
Q38181945 | Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence |
Q34342747 | Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence |
Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
Q35034473 | Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via α6-containing nicotinic receptors |
Q35651399 | Nicotinic Acetylcholine Receptor (nAChR) Dependent Chorda Tympani Taste Nerve Responses to Nicotine, Ethanol and Acetylcholine |
Q47734407 | Nicotinic acetylcholine receptors (nAChRs) are expressed in Trpm5 positive taste receptor cells (TRCs). |
Q35079043 | Nicotinic acetylcholine receptors containing the α4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption |
Q35850223 | Nicotinic acetylcholine receptors containing the α4 subunit modulate alcohol reward |
Q37346923 | Nicotinic acetylcholine receptors containing the α6 subunit contribute to ethanol activation of ventral tegmental area dopaminergic neurons |
Q35591662 | Nicotinic acetylcholine receptors containing α6 subunits contribute to alcohol reward-related behaviours |
Q28087047 | Nicotinic receptor modulation to treat alcohol and drug dependence |
Q34661812 | Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats |
Q35287506 | Pharmacological stress is required for the anti-alcohol effect of the α3β4* nAChR partial agonist AT-1001 |
Q36039402 | Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. |
Q92501996 | Promoting activity of (α4)3(β2)2 nicotinic cholinergic receptors reduces ethanol consumption |
Q37463998 | Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependence |
Q36581617 | Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism |
Q37894276 | Recent advances in gene manipulation and nicotinic acetylcholine receptor biology. |
Q35184641 | Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. |
Q36821822 | Reward Anticipation Is Differentially Modulated by Varenicline and Nicotine in Smokers |
Q36342934 | Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research |
Q35690145 | Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders |
Q48305886 | The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target? |
Q37404736 | The effects of varenicline on alcohol seeking and self-administration in baboons. |
Q36494806 | The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats. |
Q47550611 | The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption |
Q35788371 | The role of varenicline on alcohol-primed self-administration and seeking behavior in rats |
Q37514878 | The α5 neuronal nicotinic acetylcholine receptor subunit plays an important role in the sedative effects of ethanol but does not modulate consumption in mice |
Q34837643 | The α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area |
Q36111599 | The α6 nicotinic acetylcholine receptor subunit influences ethanol-induced sedation |
Q37687946 | Utility of genetically modified mice for understanding the neurobiology of substance use disorders |
Q38129470 | Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction? |
Q34271996 | Varenicline decreases alcohol consumption in heavy-drinking smokers |
Q33929766 | Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens |
Q43188062 | Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats. |
Q47676125 | Varenicline modulates ethanol and saccharin consumption in adolescent male and female C57BL/6J mice |
Q30454909 | Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements |
Q35046256 | Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats |
Q47778030 | α6β2 nicotinic acetylcholine receptors influence locomotor activity and ethanol consumption |
Search more.